239 related articles for article (PubMed ID: 1909923)
21. Effects of acute and chronic clozapine and haloperidol administration on 3-methoxytyramine accumulation in rat prefrontal cortex, nucleus accumbens and striatum.
Egan MF; Karoum F; Wyatt RJ
Eur J Pharmacol; 1991 Jun; 199(2):191-9. PubMed ID: 1954977
[TBL] [Abstract][Full Text] [Related]
22. Ceruletide, a cholecystokinin-related peptide, attenuates haloperidol-induced increase in dopamine release from the rat striatum: an in vivo microdialysis study.
Kihara T; Ikeda M; Matsushita A
Brain Res; 1990 Jun; 519(1-2):44-9. PubMed ID: 2397417
[TBL] [Abstract][Full Text] [Related]
23. Tyrosine augments acute clozapine- but not haloperidol-induced dopamine release in the medial prefrontal cortex of the rat: an in vivo microdialysis study.
Jaskiw GE; Collins KA; Pehek EA; Yamamoto BK
Neuropsychopharmacology; 2001 Jul; 25(1):149-56. PubMed ID: 11377928
[TBL] [Abstract][Full Text] [Related]
24. Acute haloperidol administration induces depolarization block of nigral dopamine neurons in rats after partial dopamine lesions.
Hollerman JR; Grace AA
Neurosci Lett; 1989 Jan; 96(1):82-8. PubMed ID: 2494609
[TBL] [Abstract][Full Text] [Related]
25. In vivo voltammetric study of 6-hydroxydopamine-induced neuronal degradation.
Nakazato T; Akiyama A
J Neurochem; 1988 Oct; 51(4):1007-13. PubMed ID: 3138384
[TBL] [Abstract][Full Text] [Related]
26. The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons.
Hollerman JR; Grace AA
Brain Res; 1990 Nov; 533(2):203-12. PubMed ID: 2126975
[TBL] [Abstract][Full Text] [Related]
27. Neurochemical effects of chronic haloperidol and lithium assessed by brain microdialysis in rats.
Hernandez L; Baptista T; Hoebel BG
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14 Suppl():S17-35. PubMed ID: 2097671
[TBL] [Abstract][Full Text] [Related]
28. Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems.
Bannon MJ; Bunney EB; Roth RH
Brain Res; 1981 Aug; 218(1-2):376-82. PubMed ID: 7272743
[TBL] [Abstract][Full Text] [Related]
29. Regulation by D2 dopamine receptors of in vivo dopamine synthesis in striata of rats and mice with experimental parkinsonism.
Richard MG; Bennett JP
Exp Neurol; 1994 Sep; 129(1):57-63. PubMed ID: 7925842
[TBL] [Abstract][Full Text] [Related]
30. Intraventricular microdialysis: a new method for determining monoamine metabolite concentrations in the cerebrospinal fluid of freely moving rats.
Becker JB; Adams F; Robinson TE
J Neurosci Methods; 1988 Jul; 24(3):259-69. PubMed ID: 2458511
[TBL] [Abstract][Full Text] [Related]
31. Studies on brain monoamine and neuropeptide systems after neonatal intracerebroventricular 6-hydroxydopamine treatment.
Luthman J; Brodin E; Sundström E; Wiehager B
Int J Dev Neurosci; 1990; 8(5):549-60. PubMed ID: 1704172
[TBL] [Abstract][Full Text] [Related]
32. Effects of intranigral substance P and neurokinin A injections on extracellular dopamine levels measured with microdialysis in the striatum and frontoparietal cortex of rats.
Reid MS; Herrera-Marschitz M; Ungerstedt U
J Neurochem; 1991 Sep; 57(3):970-4. PubMed ID: 1713616
[TBL] [Abstract][Full Text] [Related]
33. Assessment of striatal extracellular dopamine and dopamine metabolites by microdialysis in haloperidol-treated rats exhibiting oral dyskinesia.
See RE
Neuropsychopharmacology; 1993 Sep; 9(2):101-9. PubMed ID: 8216693
[TBL] [Abstract][Full Text] [Related]
34. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.
Yang J; Hu LF; Liu X; Zhou F; Ding JH; Hu G
Life Sci; 2006 Mar; 78(17):1940-4. PubMed ID: 16216278
[TBL] [Abstract][Full Text] [Related]
35. Intracerebroventricular administration of neuropeptide Y affects parameters of dopamine, glutamate and GABA activities in the rat striatum.
Kerkerian-Le Goff L; Forni C; Samuel D; Bloc A; Dusticier N; Nieoullon A
Brain Res Bull; 1992 Feb; 28(2):187-93. PubMed ID: 1596740
[TBL] [Abstract][Full Text] [Related]
36. Locomotor hyperactivity in neonatal rats following electrolytic lesions of mesocortical dopamine neurons.
Heffner TG; Heller A; Miller FE; Kotake C; Seiden LS
Brain Res; 1983 Jul; 285(1):29-37. PubMed ID: 6411289
[TBL] [Abstract][Full Text] [Related]
37. Effects of nerve growth factor on cortical and striatal acetylcholine and dopamine release in rats with cortical devascularizing lesions.
Maysinger D; Herrera-Marschitz M; Goiny M; Ungerstedt U; Cuello AC
Brain Res; 1992 Apr; 577(2):300-5. PubMed ID: 1606501
[TBL] [Abstract][Full Text] [Related]
38. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
Hársing LG; Vizi ES
Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
[TBL] [Abstract][Full Text] [Related]
39. Reduction of 3H-spiroperidol binding in rat striatum and frontal cortex by chronic amphetamine: dose response, time course and role of sustained dopamine release.
Nielsen EB; Nielsen M; Braestrup C
Psychopharmacology (Berl); 1983; 81(1):81-5. PubMed ID: 6415736
[TBL] [Abstract][Full Text] [Related]
40. Modulatory effect of dopamine on high-affinity glutamate uptake in the rat striatum.
Kerkerian L; Dusticier N; Nieoullon A
J Neurochem; 1987 Apr; 48(4):1301-6. PubMed ID: 2880932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
